PulseAugur
实时 04:45:42
实体 Bristol-Myers Squibb

Bristol-Myers Squibb

PulseAugur coverage of Bristol-Myers Squibb — every cluster mentioning Bristol-Myers Squibb across labs, papers, and developer communities, ranked by signal.

Show in brief
总计 · 30天
5
90 天内 5
发布 · 30天
0
90 天内 0
论文 · 30天
0
90 天内 0
层级分布 · 90 天
时间线
  1. 2026-05-21 partnership Bristol-Myers Squibb is deploying Anthropic's Claude across its workforce for drug discovery and operations. 来源
情绪 · 30 天

3 天有情绪数据

最近 · 第 1/1 页 · 共 5 条
  1. RESEARCH · CL_42797 ·

    Bristol-Myers Squibb deploys Anthropic's Claude for drug discovery

    Bristol-Myers Squibb, a major pharmaceutical company, is implementing Anthropic's Claude across its 30,000 employees for various functions including drug discovery and operational tasks. This partnership positions Claud…

  2. COMMENTARY · CL_30365 ·

    Pharma leaders seek stable FDA amid pricing policy concerns

    Pharmaceutical industry leaders are advocating for stability and predictability from the next Food and Drug Administration (FDA) commissioner following a period of leadership changes and uncertainty. CEOs from major dru…

  3. RESEARCH · CL_28170 ·

    Hengrui inks $15.2B global drug development deal with BMS

    Chinese pharmaceutical company Hengrui has entered into a global collaboration and licensing agreement with US giant Bristol Myers Squibb (BMS). The deal, valued at up to US$15.2 billion, involves the development of 13 …

  4. RESEARCH · CL_27831 ·

    信达生物与百时美施贵宝合作开发13个早期药物项目

    信达生物已与百时美施贵宝达成一项全球战略合作和许可协议,共同推进肿瘤、血液学和免疫学领域的13个早期项目。此次合作旨在加速创新药物的全球开发,潜在交易总价值约152亿美元。该协议也带动了创新药行业的活跃度,恒瑞医药股价上涨超过7%,其他相关公司也出现不同程度的上涨。

  5. TOOL · CL_19078 ·

    Bristol Myers Squibb leads drug industry in AI adoption for manufacturing

    Bristol Myers Squibb is an outlier among American manufacturers for its early adoption of artificial intelligence in its factories. While many companies are hesitant to integrate AI, this drugmaker is already leveraging…